Bristol Myers Squibb (BMY) Interest Coverage Ratio (2012 - 2013)
Bristol Myers Squibb (BMY) reported Interest Coverage Ratio of 7.78 for Q1 2013, down 145.13% year-over-year from 17.24 in Q1 2012, and down 145.13% on a QoQ basis from 17.24 in Q1 2012.
Bristol Myers Squibb (BMY) has 2 years of Interest Coverage Ratio data on file, last reported at 7.78 in Q1 2013.
- Quarterly Interest Coverage Ratio fell 145.13% year-over-year to 7.78 in Q1 2013, while the trailing twelve-month figure through Dec 2013 was 34.56 (up 36.06% YoY) and the FY2012 annual result came in at 4.5, down 73.29% from the prior year.
- Interest Coverage Ratio eased to 7.78 in Q1 2013 per BMY's latest filing, from 17.24 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 17.24 in Q1 2012 and bottomed at 7.78 in Q1 2013.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | - |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 23.39 |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | - |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | - |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | 4.06 |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 10.78 |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | - |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | - |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2013 | -7.78 |
| Mar 31, 2012 | 17.24 |